1st Quarter - Report

NEOGENOMICS LABORATORIES for NEOGENOMICS LABORATORIES

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Verifying Accurate Leading-edge IVCT Development Act of 2020, S. 3404

LobbyistCovered position, as disclosed
ALAN MERTZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3404 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.